
Koninklijke Philips N.V. PHG
€ 24.22
-1.66%
Geschäftsbericht 2025
hinzugefügt 14.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NYSE |
Anteile |
- |
Marktkapitalisierung |
$ 20 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
ICON Public Limited Company
ICLR
|
$ 98.33 | 0.9 % | $ 8.11 B | Nasdaq Global Select Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 13.71 | -0.22 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 155.46 | 1.83 % | $ 7.71 B | NYSE,SPB | ||
|
Bioventus
BVS
|
$ 8.62 | 0.23 % | $ 574 M | Nasdaq Global Select Market | ||
|
DexCom
DXCM
|
$ 64.24 | -1.56 % | $ 25.1 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 25.56 | 0.95 % | $ 710 M | Nasdaq Global Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 17.01 | 3.4 % | $ 906 M | Nasdaq Global Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.57 | 0.29 % | $ 19.5 B | Nasdaq Capital Market,SPB | ||
|
Guardant Health
GH
|
$ 85.49 | 1.75 % | $ 10.7 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Fulgent Genetics
FLGT
|
$ 14.77 | 0.61 % | $ 447 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Biodesix
BDSX
|
$ 17.88 | -6.63 % | $ 2.32 B | Nasdaq Global Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.83 | -1.05 % | $ 91.8 K | Nasdaq Capital Market | ||
|
Danaher Corporation
DHR
|
$ 187.32 | 0.57 % | $ 134 B | NYSE,SPB | ||
|
IQVIA Holdings
IQV
|
$ 164.72 | 1.1 % | $ 28.3 B | NYSE,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 118.94 | 2.92 % | $ 18.9 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 199.7 | -0.46 % | $ 22.2 B | NYSE,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Agilent Technologies
A
|
$ 111.51 | -0.06 % | $ 33.9 B | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.11 | -0.89 % | $ 1.41 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 9.0 | -0.99 % | $ 255 M | Nasdaq Capital Market | ||
|
Neogen Corporation
NEOG
|
$ 9.09 | -2.78 % | $ 1.97 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 16.52 | 0.12 % | $ 370 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.33 | 4.72 % | $ 399 M | Nasdaq Global Select Market,SPB | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
Medpace Holdings
MEDP
|
$ 450.41 | 1.48 % | $ 13 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 114.22 | 3.11 % | $ 4.51 B | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 173.74 | 0.49 % | $ 24.2 B | NYSE,SPB | ||
|
Personalis
PSNL
|
$ 6.72 | 1.97 % | $ 398 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 7.88 | -1.25 % | $ 1.01 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Natera
NTRA
|
$ 187.85 | -1.29 % | $ 18.5 B | Nasdaq Global Select Market,SPB | ||
|
Sotera Health Company
SHC
|
$ 13.42 | 0.71 % | $ 3.81 B | Nasdaq Global Select Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
OPKO Health
OPK
|
$ 1.19 | 2.59 % | $ 826 M | Nasdaq Global Select Market |